GPI GPI S.p.A.
GPI S.p.A. provides social-healthcare and information technology hi-tech services in Italy and internationally. It offers population health management; healthcare administration and accounting, human resources management, management systems, and payment and storage solutions; hospital information access systems, clinical, diagnostic systems, and repository and integration middleware solutions; and social-health and welfare system, territorial social-health system, continuity of care, as well as prevention, public health, and veterinary medicine solutions. The company also provides LIS, pathological anatomy, and RIS PACS imaging diagnostic information system; transfusion systems and analysis laboratory transfusion information systems; virtual care, CUP and multichannel BPO services, outpatient clinics and clinics, and 3D prosthetics technologies and services; and robot for pharmacy and automated hospital pharmacy. In addition, it offers management systems for public administration, labor information system, and payments and storage PA information systems; IT services and cyber security; and artificial intelligence, interoperability, BI and data analytics, and wearable technologies. GPI S.p.A. was founded in 1988 and is headquartered in Trento, Italy.…
Industry Peers
Health Information ServicesKey Statistics
About GPI (BIT: GPI)
›
GPI (BIT: GPI) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 6,817 employees.
The shares were at 15.04 EUR on 20 November 2026, down 0.7% over 52 weeks. Its 52-week range is 13.18 EUR to 18.68 EUR: the price is 19.5% below the high and 14.1% above the low.
At a market capitalisation of 436.79M EUR, it trades at 27.0 times trailing earnings and 14.6 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 36% for GPI. It pays a dividend yielding 3.98% (it pays out 87% of its earnings).
GPI reports return on equity of 5.3%, an operating margin of 9.0% and revenue down 1.1% year over year.
Its debt exceeds its cash by 469.90M EUR, a debt-to-equity ratio of 1.44. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 17.37 EUR is 15.5% above the current price.